Kaneka Corporation, P&SN SV

Kaneka provides process-intensification services built on core technologies including chiral transformations via biocatalysis, chemical synthesis and flow chemistry, serving as a reliable partner from early pharmaceutical development through scale-up and commercialization across the product lifecycle. Since 2010, its Belgian subsidiary Eurogentec has expanded its CDMO offering, with a longstanding goal of continuing to support customers through innovative technology development and manufacturing.